UB Paderborn / Katalog / Suche / in CDI

Photoresponsive porous materials: the design and synthesis of photochromic diarylethene-based linkers and a metal-organic framework

Chemical communications (Cambridge, England), 2014-01, Vol.50 (20), p.2653-2656

2014

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous technology and panel data: The case of the agricultural production function

Journal of development economics, 2012-09, Vol.99 (1), p.139-149

2012

Link zum Volltext

Verfügbarkeit prüfen

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy

Diabetic medicine, 2006-10, Vol.23 (10), p.1124-1129

2006

Link zum Volltext

Verfügbarkeit prüfen

Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension

Phytomedicine (Stuttgart), 2002-10, Vol.9 (7), p.581-588

2002

Link zum Volltext

Verfügbarkeit prüfen

A Cross-Country Database for Sector Investment and Capital

The World Bank economic review, 2000-05, Vol.14 (2), p.371-391

2000

Link zum Volltext

Verfügbarkeit prüfen

A106: Irbesartan results in more complete blockade of human renal at1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels

American journal of hypertension, 2000-04, Vol.13 (S2), p.151A-151A

2000

Link zum Volltext

Verfügbarkeit prüfen

A105: Extent and duration of angiotensin ii antagonistic activity of irbesartan and candesartan cilexetil

American journal of hypertension, 2000-04, Vol.13 (S2), p.150A-150A

2000

Link zum Volltext

Verfügbarkeit prüfen

Method specificity of non‐invasive blood pressure measurement: oscillometry and finger pulse pressure vs acoustic methods

British journal of clinical pharmacology, 1995-10, Vol.40 (4), p.291-297

1995

Link zum Volltext

Verfügbarkeit prüfen

Photoresponsive porous materials: the design and synthesis of photochromic diarylethene-based linkers and a metal-organic frameworkElectronic supplementary information (ESI) available: Synthetic details, digestion experiment results, additional UV/Vis spectra, crystallographic data, crystallographic refinement details. CCDC 975076-975080. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c3cc49666j

2014-02

Link zum Volltext

Verfügbarkeit prüfen

Urvater und Eiszeit. Biologisch-evolutionäres und psycholamarckistisches Denken bei Freud

Luzifer-Amor : Zeitschrift zur Geschichte der Psychoanalyse, 1991, Vol.4 (8), p.24

1991

Link zum Volltext

Verfügbarkeit prüfen

Dose-Effect and Kinetic-Dynamic Relationships of the (β-Adrenoceptor Blocking Properties of Various Doses of Talinolol in Healthy Humans

Journal of cardiovascular pharmacology, 1995-12, Vol.26 (6), p.879-888

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man

International journal of clinical pharmacology and therapeutics, 1997-10, Vol.35 (10), p.434

1997

Link zum Volltext

Verfügbarkeit prüfen

Agricultural dynamics in Thailand, Indonesia and the Philippines

The Australian journal of agricultural and resource economics, 2004-03, Vol.48 (1), p.95-126

2004

Link zum Volltext

Verfügbarkeit prüfen

Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay

Clinical pharmacology and therapeutics, 1999-10, Vol.66 (4), p.367-373

1999

Link zum Volltext

Verfügbarkeit prüfen

Agreement and reproducibility of the estimates of cardiovascular function by impedance cardiography and M‐mode echocardiography in healthy subjects

British journal of clinical pharmacology, 1992-07, Vol.34 (1), p.88-92

1992

Link zum Volltext

Verfügbarkeit prüfen

Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man

European journal of clinical pharmacology, 1992-10, Vol.43 (4), p.445-447

1992

Link zum Volltext

Verfügbarkeit prüfen

Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy

European heart journal, 1987-12, Vol.8 (suppl-M), p.3-8

1987

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Studies on the Angiotensin II Type 1 Antagonists Irbesartan and Candesartan Based on Angiotensin II Dose Response in Humans

Journal of cardiovascular pharmacology, 2002-04, Vol.39 (4), p.561-568

2002

Link zum Volltext

Verfügbarkeit prüfen

COMPARATIVE POTENCY OF VARIOUS AT 1 ANTAGONISTS USING THE SCHILD REGRESSION TECHNIQUE IN MAN: P3.27

Journal of hypertension, 2000-06, Vol.18, p.S158

2000

Link zum Volltext

Verfügbarkeit prüfen

Intersectoral Migration in Venezuela

Economic development and cultural change, 2002-01, Vol.50 (2), p.227-248

2002

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II antagonism and plasma radioreceptor‐kinetics of candesartan in man

British journal of clinical pharmacology, 1998-06, Vol.45 (6), p.567-573

1998

Link zum Volltext

Verfügbarkeit prüfen

Extent and duration of angiotensin ii antagonistic activity of irbesartan and candesartan cilexetil

American journal of hypertension, 2000-06, Vol.13 (4), p.S150-S150

2000

Link zum Volltext

Verfügbarkeit prüfen

Irbesartan results in more complete blockade of human renal at 1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels

American journal of hypertension, 2000, Vol.13 (4), p.S151-S151

2000

Link zum Volltext

Verfügbarkeit prüfen

EXTENT AND DURATION OF ANGIOTENSIN II ANTAGONISTIC ACTIVITY OF IRBESARTAN AND CANDESARTAN CILEXETIL: P3.224

Journal of hypertension, 2000-06, Vol.18, p.S209

2000

Link zum Volltext

Verfügbarkeit prüfen

IRBESARTAN RESULTS IN MORE COMPLETE BLOCKADE OF HUMAN ADRENAL AT1-RECEPTOR MEDIATED EFFECTS THAN DOES CANDESARTAN CILEXETIL AS EVIDENCED BY BLUNTED PLASMA ALDOSTERONE LEVELS: P3.225

Journal of hypertension, 2000-06, Vol.18, p.S209

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Photoresponsive porous materials: the design and synthesis of photochromic diarylethene-based linkers and a metal-organic framework

Heterogeneous technology and panel data: The case of the agricultural production function

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy

Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension

A Cross-Country Database for Sector Investment and Capital

A106: Irbesartan results in more complete blockade of human renal at1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels

A105: Extent and duration of angiotensin ii antagonistic activity of irbesartan and candesartan cilexetil

Method specificity of non‐invasive blood pressure measurement: oscillometry and finger pulse pressure vs acoustic methods

Urvater und Eiszeit. Biologisch-evolutionäres und psycholamarckistisches Denken bei Freud

Dose-Effect and Kinetic-Dynamic Relationships of the (β-Adrenoceptor Blocking Properties of Various Doses of Talinolol in Healthy Humans

Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man

Agricultural dynamics in Thailand, Indonesia and the Philippines

Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay

Agreement and reproducibility of the estimates of cardiovascular function by impedance cardiography and M‐mode echocardiography in healthy subjects

Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man

Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy

Pharmacodynamic Studies on the Angiotensin II Type 1 Antagonists Irbesartan and Candesartan Based on Angiotensin II Dose Response in Humans

COMPARATIVE POTENCY OF VARIOUS AT 1 ANTAGONISTS USING THE SCHILD REGRESSION TECHNIQUE IN MAN: P3.27

Intersectoral Migration in Venezuela

Angiotensin II antagonism and plasma radioreceptor‐kinetics of candesartan in man

Extent and duration of angiotensin ii antagonistic activity of irbesartan and candesartan cilexetil

Irbesartan results in more complete blockade of human renal at 1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels

EXTENT AND DURATION OF ANGIOTENSIN II ANTAGONISTIC ACTIVITY OF IRBESARTAN AND CANDESARTAN CILEXETIL: P3.224

IRBESARTAN RESULTS IN MORE COMPLETE BLOCKADE OF HUMAN ADRENAL AT1-RECEPTOR MEDIATED EFFECTS THAN DOES CANDESARTAN CILEXETIL AS EVIDENCED BY BLUNTED PLASMA ALDOSTERONE LEVELS: P3.225

Suchergebnisse filtern